ArticleEuropean heart journal2023

The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.

J Hans DeVries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.